Selective triggering of platelet apoptosis, platelet activation or both

Summary Anucleate platelets perform two fundamental processes, activation and apoptosis. We elaborated an approach for selective and concurrent stimulation of platelet apoptosis and/or activation, processes important in haemostasis and platelet clearance. Human platelets were treated with BH3 mimeti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of haematology 2013-04, Vol.161 (2), p.245-254
Hauptverfasser: Gyulkhandanyan, Armen V., Mutlu, Asuman, Freedman, John, Leytin, Valery
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 254
container_issue 2
container_start_page 245
container_title British journal of haematology
container_volume 161
creator Gyulkhandanyan, Armen V.
Mutlu, Asuman
Freedman, John
Leytin, Valery
description Summary Anucleate platelets perform two fundamental processes, activation and apoptosis. We elaborated an approach for selective and concurrent stimulation of platelet apoptosis and/or activation, processes important in haemostasis and platelet clearance. Human platelets were treated with BH3 mimetic ABT‐737, thrombin, calcium ionophore A23187 and matched diluents. Apoptosis was determined as mitochondrial inner membrane potential (ΔΨm) depolarization and activation as P‐selectin exposure. At optimal treatment conditions (90–180 min, 37°C), ABT‐737 predominantly induced apoptosis, when 77–81% platelets undergo only ΔΨm depolarization. The ABT‐737 impact on ΔΨm depolarization is strongly time‐ and temperature‐dependent, and much higher at 37°C than at room temperature. In contrast, when platelets were treated with thrombin for 15–90 min at either temperature, activation‐only was predominantly (79–85%) induced, whereas A23187 triggers both apoptosis and activation (73–81%) when platelets were treated for 15–60 min at 37°C or 15–90 min at room temperature. These data demonstrate that, depending on the triggering stimulus, platelets predominantly undergo ΔΨm depolarization‐only, P‐selectin exposure‐only, or both responses, indicating that platelet apoptosis and activation are different phenomena driven by different mechanisms. The described model provides a basis for studying differential pharmacological manipulation of platelet apoptosis and activation and their role in haemostasis, thrombosis and platelet clearance.
doi_str_mv 10.1111/bjh.12237
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1753456320</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1324386702</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4237-ec52f7c60f9b5c80c02bf9b722abf3ac91f164f77cbcef7b95f19a82986c896c3</originalsourceid><addsrcrecordid>eNqF0E1PwyAYB3BiNG5OD34B04uJJtbx0kI56qKbZokH9dxQhI2lKxWYZt9eZufLxcgF8vDjecgfgGMEL1Fcw2oxv0QYE7YD-ojQPMUoQ7ugDyFkKYJZ0QMH3i8gRATmaB_0MCG8yCnvg_GjqpUM5k0lwZnZTDnTzBKrk7YWIV6FRLS2DdYbf_GrtnkhgrFNYl1S2TA_BHta1F4dbfcBeL69eRpN0unD-G50NU1lFv-XKpljzSSFmle5LKCEuIpHhrGoNBGSI41ophmTlVSaVTzXiIsC84LKglNJBuCs69s6-7pSPpRL46Wqa9Eou_IlYjnJckow_J8SnJGCMogjPe-odNZ7p3TZOrMUbl0iWG4iLmPE5WfE0Z5s266qpXr5ll-ZRnC6BcJLUWsnGmn8j2M4w5Rn0Q07925qtf57Ynl9P-lGfwA3-ZIN</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1324386702</pqid></control><display><type>article</type><title>Selective triggering of platelet apoptosis, platelet activation or both</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Online Library Free Content</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Gyulkhandanyan, Armen V. ; Mutlu, Asuman ; Freedman, John ; Leytin, Valery</creator><creatorcontrib>Gyulkhandanyan, Armen V. ; Mutlu, Asuman ; Freedman, John ; Leytin, Valery</creatorcontrib><description>Summary Anucleate platelets perform two fundamental processes, activation and apoptosis. We elaborated an approach for selective and concurrent stimulation of platelet apoptosis and/or activation, processes important in haemostasis and platelet clearance. Human platelets were treated with BH3 mimetic ABT‐737, thrombin, calcium ionophore A23187 and matched diluents. Apoptosis was determined as mitochondrial inner membrane potential (ΔΨm) depolarization and activation as P‐selectin exposure. At optimal treatment conditions (90–180 min, 37°C), ABT‐737 predominantly induced apoptosis, when 77–81% platelets undergo only ΔΨm depolarization. The ABT‐737 impact on ΔΨm depolarization is strongly time‐ and temperature‐dependent, and much higher at 37°C than at room temperature. In contrast, when platelets were treated with thrombin for 15–90 min at either temperature, activation‐only was predominantly (79–85%) induced, whereas A23187 triggers both apoptosis and activation (73–81%) when platelets were treated for 15–60 min at 37°C or 15–90 min at room temperature. These data demonstrate that, depending on the triggering stimulus, platelets predominantly undergo ΔΨm depolarization‐only, P‐selectin exposure‐only, or both responses, indicating that platelet apoptosis and activation are different phenomena driven by different mechanisms. The described model provides a basis for studying differential pharmacological manipulation of platelet apoptosis and activation and their role in haemostasis, thrombosis and platelet clearance.</description><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/bjh.12237</identifier><identifier>PMID: 23398569</identifier><identifier>CODEN: BJHEAL</identifier><language>eng</language><publisher>Oxford: Blackwell</publisher><subject>ABT‐737 and thrombin ; Apoptosis - drug effects ; Biological and medical sciences ; Biphenyl Compounds - pharmacology ; Blood Platelets - metabolism ; Ca2+‐ionophore A23187 ; Calcimycin - pharmacology ; Calcium Ionophores - pharmacology ; Female ; Hematologic and hematopoietic diseases ; Hemostatics - pharmacology ; Hot Temperature ; Humans ; Male ; Medical sciences ; Membrane Potential, Mitochondrial - drug effects ; mitochondrial membrane depolarization ; Nitrophenols - pharmacology ; P-Selectin - metabolism ; Piperazines - pharmacology ; Platelet Activation - drug effects ; platelet apoptosis and activation ; P‐selectin exposure ; Sulfonamides - pharmacology ; Thrombin - pharmacology ; Time Factors ; Tumors</subject><ispartof>British journal of haematology, 2013-04, Vol.161 (2), p.245-254</ispartof><rights>2013 Blackwell Publishing Ltd</rights><rights>2014 INIST-CNRS</rights><rights>2013 Blackwell Publishing Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4237-ec52f7c60f9b5c80c02bf9b722abf3ac91f164f77cbcef7b95f19a82986c896c3</citedby><cites>FETCH-LOGICAL-c4237-ec52f7c60f9b5c80c02bf9b722abf3ac91f164f77cbcef7b95f19a82986c896c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fbjh.12237$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fbjh.12237$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=27242694$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23398569$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gyulkhandanyan, Armen V.</creatorcontrib><creatorcontrib>Mutlu, Asuman</creatorcontrib><creatorcontrib>Freedman, John</creatorcontrib><creatorcontrib>Leytin, Valery</creatorcontrib><title>Selective triggering of platelet apoptosis, platelet activation or both</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><description>Summary Anucleate platelets perform two fundamental processes, activation and apoptosis. We elaborated an approach for selective and concurrent stimulation of platelet apoptosis and/or activation, processes important in haemostasis and platelet clearance. Human platelets were treated with BH3 mimetic ABT‐737, thrombin, calcium ionophore A23187 and matched diluents. Apoptosis was determined as mitochondrial inner membrane potential (ΔΨm) depolarization and activation as P‐selectin exposure. At optimal treatment conditions (90–180 min, 37°C), ABT‐737 predominantly induced apoptosis, when 77–81% platelets undergo only ΔΨm depolarization. The ABT‐737 impact on ΔΨm depolarization is strongly time‐ and temperature‐dependent, and much higher at 37°C than at room temperature. In contrast, when platelets were treated with thrombin for 15–90 min at either temperature, activation‐only was predominantly (79–85%) induced, whereas A23187 triggers both apoptosis and activation (73–81%) when platelets were treated for 15–60 min at 37°C or 15–90 min at room temperature. These data demonstrate that, depending on the triggering stimulus, platelets predominantly undergo ΔΨm depolarization‐only, P‐selectin exposure‐only, or both responses, indicating that platelet apoptosis and activation are different phenomena driven by different mechanisms. The described model provides a basis for studying differential pharmacological manipulation of platelet apoptosis and activation and their role in haemostasis, thrombosis and platelet clearance.</description><subject>ABT‐737 and thrombin</subject><subject>Apoptosis - drug effects</subject><subject>Biological and medical sciences</subject><subject>Biphenyl Compounds - pharmacology</subject><subject>Blood Platelets - metabolism</subject><subject>Ca2+‐ionophore A23187</subject><subject>Calcimycin - pharmacology</subject><subject>Calcium Ionophores - pharmacology</subject><subject>Female</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Hemostatics - pharmacology</subject><subject>Hot Temperature</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Membrane Potential, Mitochondrial - drug effects</subject><subject>mitochondrial membrane depolarization</subject><subject>Nitrophenols - pharmacology</subject><subject>P-Selectin - metabolism</subject><subject>Piperazines - pharmacology</subject><subject>Platelet Activation - drug effects</subject><subject>platelet apoptosis and activation</subject><subject>P‐selectin exposure</subject><subject>Sulfonamides - pharmacology</subject><subject>Thrombin - pharmacology</subject><subject>Time Factors</subject><subject>Tumors</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0E1PwyAYB3BiNG5OD34B04uJJtbx0kI56qKbZokH9dxQhI2lKxWYZt9eZufLxcgF8vDjecgfgGMEL1Fcw2oxv0QYE7YD-ojQPMUoQ7ugDyFkKYJZ0QMH3i8gRATmaB_0MCG8yCnvg_GjqpUM5k0lwZnZTDnTzBKrk7YWIV6FRLS2DdYbf_GrtnkhgrFNYl1S2TA_BHta1F4dbfcBeL69eRpN0unD-G50NU1lFv-XKpljzSSFmle5LKCEuIpHhrGoNBGSI41ophmTlVSaVTzXiIsC84LKglNJBuCs69s6-7pSPpRL46Wqa9Eou_IlYjnJckow_J8SnJGCMogjPe-odNZ7p3TZOrMUbl0iWG4iLmPE5WfE0Z5s266qpXr5ll-ZRnC6BcJLUWsnGmn8j2M4w5Rn0Q07925qtf57Ynl9P-lGfwA3-ZIN</recordid><startdate>201304</startdate><enddate>201304</enddate><creator>Gyulkhandanyan, Armen V.</creator><creator>Mutlu, Asuman</creator><creator>Freedman, John</creator><creator>Leytin, Valery</creator><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>201304</creationdate><title>Selective triggering of platelet apoptosis, platelet activation or both</title><author>Gyulkhandanyan, Armen V. ; Mutlu, Asuman ; Freedman, John ; Leytin, Valery</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4237-ec52f7c60f9b5c80c02bf9b722abf3ac91f164f77cbcef7b95f19a82986c896c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>ABT‐737 and thrombin</topic><topic>Apoptosis - drug effects</topic><topic>Biological and medical sciences</topic><topic>Biphenyl Compounds - pharmacology</topic><topic>Blood Platelets - metabolism</topic><topic>Ca2+‐ionophore A23187</topic><topic>Calcimycin - pharmacology</topic><topic>Calcium Ionophores - pharmacology</topic><topic>Female</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Hemostatics - pharmacology</topic><topic>Hot Temperature</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Membrane Potential, Mitochondrial - drug effects</topic><topic>mitochondrial membrane depolarization</topic><topic>Nitrophenols - pharmacology</topic><topic>P-Selectin - metabolism</topic><topic>Piperazines - pharmacology</topic><topic>Platelet Activation - drug effects</topic><topic>platelet apoptosis and activation</topic><topic>P‐selectin exposure</topic><topic>Sulfonamides - pharmacology</topic><topic>Thrombin - pharmacology</topic><topic>Time Factors</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gyulkhandanyan, Armen V.</creatorcontrib><creatorcontrib>Mutlu, Asuman</creatorcontrib><creatorcontrib>Freedman, John</creatorcontrib><creatorcontrib>Leytin, Valery</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gyulkhandanyan, Armen V.</au><au>Mutlu, Asuman</au><au>Freedman, John</au><au>Leytin, Valery</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Selective triggering of platelet apoptosis, platelet activation or both</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>2013-04</date><risdate>2013</risdate><volume>161</volume><issue>2</issue><spage>245</spage><epage>254</epage><pages>245-254</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><coden>BJHEAL</coden><abstract>Summary Anucleate platelets perform two fundamental processes, activation and apoptosis. We elaborated an approach for selective and concurrent stimulation of platelet apoptosis and/or activation, processes important in haemostasis and platelet clearance. Human platelets were treated with BH3 mimetic ABT‐737, thrombin, calcium ionophore A23187 and matched diluents. Apoptosis was determined as mitochondrial inner membrane potential (ΔΨm) depolarization and activation as P‐selectin exposure. At optimal treatment conditions (90–180 min, 37°C), ABT‐737 predominantly induced apoptosis, when 77–81% platelets undergo only ΔΨm depolarization. The ABT‐737 impact on ΔΨm depolarization is strongly time‐ and temperature‐dependent, and much higher at 37°C than at room temperature. In contrast, when platelets were treated with thrombin for 15–90 min at either temperature, activation‐only was predominantly (79–85%) induced, whereas A23187 triggers both apoptosis and activation (73–81%) when platelets were treated for 15–60 min at 37°C or 15–90 min at room temperature. These data demonstrate that, depending on the triggering stimulus, platelets predominantly undergo ΔΨm depolarization‐only, P‐selectin exposure‐only, or both responses, indicating that platelet apoptosis and activation are different phenomena driven by different mechanisms. The described model provides a basis for studying differential pharmacological manipulation of platelet apoptosis and activation and their role in haemostasis, thrombosis and platelet clearance.</abstract><cop>Oxford</cop><pub>Blackwell</pub><pmid>23398569</pmid><doi>10.1111/bjh.12237</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1048
ispartof British journal of haematology, 2013-04, Vol.161 (2), p.245-254
issn 0007-1048
1365-2141
language eng
recordid cdi_proquest_miscellaneous_1753456320
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Wiley Online Library Free Content; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects ABT‐737 and thrombin
Apoptosis - drug effects
Biological and medical sciences
Biphenyl Compounds - pharmacology
Blood Platelets - metabolism
Ca2+‐ionophore A23187
Calcimycin - pharmacology
Calcium Ionophores - pharmacology
Female
Hematologic and hematopoietic diseases
Hemostatics - pharmacology
Hot Temperature
Humans
Male
Medical sciences
Membrane Potential, Mitochondrial - drug effects
mitochondrial membrane depolarization
Nitrophenols - pharmacology
P-Selectin - metabolism
Piperazines - pharmacology
Platelet Activation - drug effects
platelet apoptosis and activation
P‐selectin exposure
Sulfonamides - pharmacology
Thrombin - pharmacology
Time Factors
Tumors
title Selective triggering of platelet apoptosis, platelet activation or both
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T10%3A34%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Selective%20triggering%20of%20platelet%20apoptosis,%20platelet%20activation%20or%20both&rft.jtitle=British%20journal%20of%20haematology&rft.au=Gyulkhandanyan,%20Armen%20V.&rft.date=2013-04&rft.volume=161&rft.issue=2&rft.spage=245&rft.epage=254&rft.pages=245-254&rft.issn=0007-1048&rft.eissn=1365-2141&rft.coden=BJHEAL&rft_id=info:doi/10.1111/bjh.12237&rft_dat=%3Cproquest_cross%3E1324386702%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1324386702&rft_id=info:pmid/23398569&rfr_iscdi=true